Inhibitor Therapeutics Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Frank O'Donnell
Chief executive officer
US$1.1m
Total compensation
| CEO salary percentage | 54.9% |
| CEO tenure | 1.9yrs |
| CEO ownership | 0.03% |
| Management average tenure | no data |
| Board average tenure | 1.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$3m |
| Jun 30 2024 | n/a | n/a | -US$3m |
| Mar 31 2024 | n/a | n/a | -US$3m |
| Dec 31 2023 | US$1m | US$598k | -US$3m |
| Sep 30 2023 | n/a | n/a | US$10m |
| Jun 30 2023 | n/a | n/a | US$11m |
| Mar 31 2023 | n/a | n/a | US$12m |
| Dec 31 2022 | US$756k | US$30k | US$12m |
Compensation vs Market: Frank's total compensation ($USD1.09M) is above average for companies of similar size in the US market ($USD647.72K).
Compensation vs Earnings: Frank's compensation has increased whilst the company is unprofitable.
CEO
Frank O'Donnell (74 yo)
1.9yrs
Tenure
US$1,089,337
Compensation
Dr. Francis E. O'Donnell, Jr. also known as Frank, M. D. is a Founder of Inhibitor Therapeutics Inc and serves as its Executive Chairman & CEO since December 13, 2022. He is the Founder of BioDelivery Scie...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 1.9yrs | US$1.09m | 0.029% $ 3.8k | |
| Independent Director | 1.9yrs | US$23.50k | 0.66% $ 85.6k | |
| Non-Independent Director | 1.3yrs | US$5.50k | 13.67% $ 1.8m | |
| Independent Director | 1.9yrs | US$23.50k | 0.029% $ 3.8k | |
| Director | less than a year | US$16.75k | 0.52% $ 67.9k | |
| Independent Director | 1.5yrs | US$11.03k | 0.047% $ 6.1k | |
| Chairperson of the Scientific Advisory Board | 1.1yrs | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
1.1yrs
Average Tenure
67yo
Average Age
Experienced Board: INTI's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.